Shionogi Releases Carbapenem Antibiotic Kit.Tokyo, Japan, June 13, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Shionogi has launched Finibax 0.25g IV Solution Kit, a kit for its proprietary antibiotic agent Finibax (doripenem hydrate hydrate (hī`drāt), chemical compound that contains water. A common hydrate is the familiar blue vitriol, a crystalline form of cupric sulfate. Chemically, it is cupric sulfate pentahydrate, CuSO4·5H2O. ). The new kit, which offers an antibiotic agent and solution together, simplifies the dissolution procedure, preventing medical errors. Finibax, which was initially launched in September 2005, has a wide antibacterial antibacterial /an·ti·bac·te·ri·al/ (-bak-ter´e-al) destroying or suppressing growth or reproduction of bacteria; also, an agent that does this. an·ti·bac·te·ri·al adj. spectrum. It exerts strong antibacterial effects against gram-positive and gram-negative bacteria, aerobes, anaerobes as well as Pseudomonas aeruginosa Pseudomonas aeruginosa A normal soil inhabitant and human saprophyte that may contaminate various solutions in a hospital, causing opportunistic infection in weakened Pts Clinical Infective endocarditis in IVDAs, RTIs, UTIs, bacteremia, meningitis, 'malignant' . The company expects that the new kit will contribute to the treatment of various bacterial infectious diseases. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion